10-K: Pineapple Express Cannabis Company Reports Fiscal Year 2024 Results, Cites Ongoing Challenges

Pineapple Express Cannabis Company's annual report reveals a net loss of $59,497 for fiscal year 2024 and highlights ongoing concerns about the company's ability to continue as a going concern.

Summary

• Pineapple Express Cannabis Company reported a net loss of $59,497 for the fiscal year ended January 31, 2024, compared to a net loss of $44,443 in the previous year.
• The company's revenue was $0 for fiscal year 2024, down from $5,385 in fiscal year 2023.
• Operating expenses increased to $59,497 in 2024 from $21,704 in 2023, including significant professional fees and bad debt expenses.
• The company's accumulated deficit reached $642,493 by the end of fiscal year 2024.
• The report raises substantial doubt about the company's ability to continue as a going concern due to operating losses and minimal cash flow.
• The company is reliant on additional investment capital to fund operating expenses and plans to raise funds through capital markets and income from its 50% equity method investee.
• The company has a 50% stake in Pineapple Consolidated Inc. (PCI), which operates cannabis retail ventures.
• PCI has management contracts with nine entities, sharing 10% of revenue.
• The company has no employees and is managed by a single officer and director.
• The company's common stock is traded on the OTC Pink Market and is not listed on a national securities exchange.

Sentiment

Score: 2

Explanation: The document paints a very negative picture of the company's financial health, with no revenue, increasing losses, and a going concern warning. The lack of operational progress and reliance on external funding contribute to a low sentiment score.

Positives

• The company has a 50% stake in Pineapple Consolidated Inc. (PCI), which operates cannabis retail ventures and has management contracts with nine entities.
• The company is actively seeking to raise additional funds through capital markets and income from its 50% equity method investee.

Negatives

• The company experienced a significant increase in net loss from $44,443 to $59,497.
• The company's revenue decreased to $0 in fiscal year 2024.
• Operating expenses more than doubled, rising from $21,704 to $59,497.
• The company has an accumulated deficit of $642,493.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company has no employees and is managed by a single officer and director.
• The company's stock trades on the OTC Pink Market, which is a thinly traded market.

Risks

• The company has a limited operating history and operates in a new and uncertain industry.
• The company's profitability is uncertain and may be affected by economic conditions and changes in the market for cannabis.
• Cannabis remains illegal under federal law, which could impact the company's operations.
• The company faces strong opposition from well-funded businesses, such as the pharmaceutical industry.
• There is uncertainty regarding the availability of U.S. federal patent and trademark protection.
• The company may have difficulty enforcing contracts due to the nature of its business.
• The company and its clients may have difficulty accessing banking services.
• The company may have difficulty obtaining insurance.
• The company faces intense competition and has limited capital and resources compared to many competitors.
• The company's growth may be limited, and it may not be able to effectively control and manage its growth.
• The company is subject to complex laws and regulations, including environmental laws.
• The company is subject to the Internal Revenue Code (IRC) Section 280E, which disallows ordinary and necessary business deductions.
• The company's stock is traded on the OTC Pink Market, which is a thinly traded market.
• The company may experience dilution of ownership interests due to future issuance of additional shares.
• The company is subject to the penny stock rules of the SEC.
• The company's Articles of Incorporation provide that the Eighth Judicial District Court of Clark County, Nevada will be the sole and exclusive forum for substantially all disputes between the company and its stockholders.

Future Outlook

The company anticipates being dependent on additional investment capital to fund operating expenses and intends to raise funds through capital markets and income from its 50% equity method investee. Management believes that current trends toward lower capital investment in start-up companies pose the most significant challenge to the company's success over the next year and in future years.

Management Comments

• Management believes that current trends toward lower capital investment in start-up companies pose the most significant challenge to the Company's success over the next year and in future years.
• Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
• Management intends to position itself so that it will be able to raise additional funds through the capital markets and also through income from its 50 % equity method investee.

Industry Context

The company operates in the cannabis industry, which is subject to evolving regulations and market conditions. The company's performance is affected by the legal status of cannabis at the federal and state levels, as well as competition from other companies in the industry. The company's reliance on external funding and the performance of its investee, PCI, are also key factors in its success.

Comparison to Industry Standards

• The company's financial performance, with $0 revenue and a significant net loss, is notably weaker than many established cannabis companies.
• Companies like Curaleaf, Trulieve, and Green Thumb Industries, which are major players in the cannabis industry, report substantial revenues and are often profitable or have a clear path to profitability.
• The company's reliance on a single officer and director is not typical of larger, more established cannabis companies, which usually have a more robust management team.
• The company's trading on the OTC Pink Market indicates a lower level of investor confidence and liquidity compared to companies listed on major exchanges like NASDAQ or NYSE.
• The company's lack of revenue and significant operating expenses are not in line with industry standards for companies that have been operating for several years.

Management Changes

Corporate Governance

Legal Proceedings

• There are no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company or has a material interest adverse to the Company.

Related Party Transactions

• The Company subleases office space from PCI at no charge.
• The Company has a 50% equity method investment in PCI.
• The Company's share of $905,580 from its related party PCI equity method investee was not recognized due to collectability concerns.

Stakeholder Impact

• Shareholders face significant risks due to the company's financial condition and the speculative nature of its business.
• Employees are not currently impacted as the company has no employees.
• Customers of PCI's retail ventures may be indirectly affected by the company's financial performance.
• Suppliers and creditors may face increased risk due to the company's financial instability.

Next Steps

• The company intends to raise additional funds through the capital markets.
• The company plans to continue to monitor the situation and may adjust its current business plans as more information and guidance become available.
• The company will attempt to raise the necessary funds to proceed with all phases of its plan of operation.

Key Dates

Keywords

cannabis, marijuana, retail, incubator, investment, financial results, OTC Pink Market, Pineapple Express, Ananas Growth Ventures, Pineapple Consolidated Inc.